NASDAQ
Krystal Biotech, Inc. (KRYS) has a current ratio of 9.95x as of Monday, May 25, 2026. This represents a 28.30% decrease compared to its 12-month average of 13.88x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.